C‐Jun N‐Terminal Kinase 2 Promotes Graft Injury via the Mitochondrial Permeability Transition After Mouse Liver Transplantation

The c‐Jun N‐terminal kinase (JNK) pathway enhances graft injury after liver transplantation (LT). We hypothesized that the JNK2 isoform promotes graft injury via the mitochondrial permeability transition (MPT). Livers of C57BL/6J (wild‐type, WT) and JNK2 knockout (KO) mice were transplanted into WT...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of transplantation Vol. 8; no. 9; pp. 1819 - 1828
Main Authors Theruvath, T. P., Czerny, C., Ramshesh, V. K., Zhong, Z., Chavin, K. D., Lemasters, J. J.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.09.2008
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The c‐Jun N‐terminal kinase (JNK) pathway enhances graft injury after liver transplantation (LT). We hypothesized that the JNK2 isoform promotes graft injury via the mitochondrial permeability transition (MPT). Livers of C57BL/6J (wild‐type, WT) and JNK2 knockout (KO) mice were transplanted into WT recipients after 30 h of cold storage in UW solution. Injury after implantation was assessed by serum ALT, histological necrosis, TUNEL, Caspase 3 activity, 30‐day survival, and cytochrome c and 4‐hydroxynonenal immunostaining. Multiphoton microscopy after LT monitored mitochondrial membrane potential in vivo. After LT, ALT increased three times more in WT compared to KO (p < 0.05). Necrosis and TUNEL were more than two times greater in WT than KO (p < 0.05). Immunostaining showed a >80% decrease of mitochondrial cytochrome c release in KO compared to WT (p < 0.01). Lipid peroxidation was similarly decreased. Every KO graft but one survived longer than all WT grafts (p < 0.05, Kaplan‐Meier). After LT, depolarization of mitochondria occurred in 73% of WT hepatocytes, which decreased to 28% in KO (p < 0.05). In conclusion, donor JNK2 promotes injury after mouse LT via the MPT. MPT inhibition using specific JNK2 inhibitors may be useful in protecting grafts against adverse outcomes from ischemia/reperfusion injury. Deficiency of c‐Jun N‐terminal kinase 2 (JNK2) improves mitochondrial function, mitigates storage/reperfusion injury and improves survival of mouse liver grafts.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1600-6135
1600-6143
DOI:10.1111/j.1600-6143.2008.02336.x